Center for American Progress September 17, 2020
Maura Calsyn and Thomas Waldrop

Introduction and summary

Lowering prescription drug prices continues to be a top health care priority for Americans.1 The American people want the government to take significant, meaningful actions to lower the prices of prescription drugs, and the coronavirus pandemic has further underscored the importance of ensuring that essential medicines are priced affordably—for both the health care system and individuals. As a number of treatments for the virus have emerged and clinical trials for COVID-19 vaccines continue to advance, there is a growing danger that these lifesaving treatments could have price tags that put them out of reach for millions of Americans.2

Action to lower the prices of prescription drugs is also an issue of health equity. Black Americans...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Healthcare System, Insurance, Patient / Consumer, Pharma / Biotech, Precision Medicine, Pricing / Spending, Provider
Biopharma M&A more than doubled in the first quarter compared to the year prior: report
23andMe: What If …
Bruker brokers $392M deal for frayed NanoString
Pharma Pulse 4/18/24: Is it Fair Certain Biotech Investors Get an Early Look? The Health and Healthcare of Millennials & more
Pharmacies Should Adopt Proactive Health, Wellness to Help Patients

Share This Article